THE EFFECT OF A DUAL RECEPTOR GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON AGONIST, COTADUTIDE, ON SERUM METABOLOME IN BIOPSY PROVEN NON-CIRRHOTIC NASH WITH FIBROSIS

被引：0
|
作者：
Daniels, Samuel J. [1 ]
Robertson, Darren [1 ]
Challis, Benjamin [2 ]
Sanyal, Arun J. [3 ]
Shankar, Sudha S. [4 ]
机构：
[1] Astrazeneca, Early Clin Dev Cardiovasc Renal & Metab, Biopharmaceut R&D, Cambridge, England
[2] Astrazeneca, Translat Sci & Expt Med, Res & Early Dev, Cardiovasc Renal & Metab,Biopharmaceut R&D, Cambridge, England
[3] Stravitz Sanyal Inst Liver Dis & Metab Hlth, VCU Sch Med, Dept Internal Med, Richmond, VA USA
[4] Astrazeneca, Early & Late Clin Dev, Cardiovasc Renal & Metab, Biopharmaceut R& D, Cambridge, England
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
101
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [1] Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist
    Parker, Victoria E. R.
    Robertson, Darren
    Wang, Tao
    Hornigold, David C.
    Petrone, Marcella
    Cooper, Aidan T.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Schlichthaar, Heike
    Klaus, Beate
    Ambery, Philip D.
    Meier, Juris J.
    Hirshberg, Boaz
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 803 - 820
  • [2] Cotadutide (MEDI0382), a dual receptor agonist with balanced glucagon-like peptide-1 and glucagon activity, modulates hepatic glycogen stores
    Parker, V. E.
    Robertson, D.
    Hansen, L.
    Ambery, P. D.
    Esterline, R.
    Jermutus, L.
    Chang, Y. -T.
    Petrone, M.
    Johansson, E.
    Johansson, L.
    Sjoberg, F.
    Hirshberg, B.
    DIABETOLOGIA, 2019, 62 : S58 - S59
  • [3] Cotadutide (medi0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Modulates Hepatic Glycogen and Fat Content
    Robertson, Darren
    Hansen, Lars
    Ambery, Philip
    Esterline, Russell L.
    Jermutus, Lutz
    Chang, Yi-Ting
    Petrone, Marcella
    Johansson, Edvin
    Johansson, Lars
    Sjoberg, Folke B.
    Parker, Victoria
    DIABETES, 2020, 69
  • [4] Glucagon-like peptide-1 receptor
    Krashes, Michael
    CURRENT BIOLOGY, 2024, 34 (23) : R1163 - R1164
  • [5] EFFECT OF GLUCAGON ON SECRETION OF GLUCAGON-LIKE PEPTIDE-1
    SHIMA, K
    OHBOSHI, C
    SATO, M
    HIROTA, M
    HORMONE AND METABOLIC RESEARCH, 1988, 20 (02) : 123 - 124
  • [6] Phase I Study of Glucagon-like Peptide-1/Glucagon Receptor Dual Agonist BI 456906 in Obesity
    Arrubla, Jorge
    Schoelch, Corinna
    Plum-Moerschel, Leona
    Kapitza, Christoph
    Lamers, Daniela
    Thamer, Claus
    Hennige, Anita M.
    OBESITY, 2021, 29 : 139 - 140
  • [7] Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin
    Foer, Dinah
    Beeler, Patrick E.
    Cui, Jing
    Snyder, William E.
    Mashayekhi, Mona
    Nian, Hui
    Luther, James M.
    Karlson, Elizabeth W.
    Boyce, Joshua A.
    Cahill, Katherine N.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 469 - 473
  • [8] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [9] Glucagon-like peptide-1 receptor agonist use in pregnancy: a review
    Drummond, Rosa F.
    Seif, Karl E.
    Reece, Albert
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2025, 232 (01) : 17 - 25
  • [10] Glucagon-Like Peptide-1 Receptor Agonist Treatment in Liver Cirrhosis
    Hanng, Cheng
    Danpanichkul, Pojsakorn
    Muthiah, Mark
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04)
12345